Merus Completes Acquisition of rights from UCB, Announces Q1 2016 Earnings Release Date

Merus Labs International Inc. (TSX:MSL, NASDAQ:MSLI) announced has completed the previously announced acquisition of rights to Elantan®, Isoket® and Deponit® in Europe and select other markets from UCB.
According to the press release:

Merus also announced today that it will release its fiscal earnings for the first quarter of fiscal 2016 after market close on Thursday, February 11, 2016. Merus will hold a conference call at 8:30am ET on Friday, February 12, 2016 to discuss the results. Conference call details will be provided in the results press release.

Click here to view the full press release.